Clinical trial
Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck…
NCT00167908 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00167908 |
|---|---|
| Title | Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer |
| Official title | Pilot Study to Test Whether Amifostine Can Further Protect Salivary Function in Head and Neck Cancer Patients Treated With IMRT |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | Ethyol (drug) |
| Enrollment | 27 |
| Start date | Oct 1, 2001 |
| Completion | May 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Feb 4, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: